| Properties | Information | |
|---|---|---|
| PhytoCAT-ID | PhytoCAT-1294 | |
| Phytochemical name or plant extracts | 3-O-cis-p-coumaroyltormentic acid | |
| PMID | 23479388 | |
| Literature evidence | Most of these compounds showed significant cytotoxic activities against four human cancer cell lines (A549, HCT116, MDA-MB-231, and CCRF-CEM), and the structure-activity relationships are also discussed. | |
| IUPAC name | (1R,2R,4aS,6aR,6aS,6bR,8aR,10R,11R,12aR,14bS)-1,11-dihydroxy-10-[(Z)-3-(4-hydroxyphenyl)prop-2-enoyl]oxy-1,2,6a,6b,9,9,12a-heptamethyl-2,3,4,5,6,6a,7,8,8a,10,11,12,13,14b-tetradecahydropicene-4a-carboxylic acid | |
| Phytochemicals’ class or type of plant extracts | Triterpenoid | |
| Source of phytochemicals or plant Extracts | Prinsepia utilis Royle | |
| Geographical availability | Assam, China South-Central, East Himalaya, India, Myanmar, Nepal, Pakistan, Tibet, West Himalaya | |
| Plant parts | Aerial parts | |
| Other cancers | Breast cancer, Lung cancer, Colon cancer, Leukemia | |
| Target gene or protein | NA | |
| Gene or Protein evidence | NA | |
| Target pathways | NA | |
| IC50 | 16.2 ± 1.1 µM against MDA-MB-231 | |
| Potency | Most of these compounds showed significant cytotoxic activities against four human cancer cell lines (A549, HCT116, MDA-MB-231, and CCRF-CEM), and the structure-activity relationships are also discussed. | |
| Cell line/ mice model | A549, HCT116, MDA-MB-231, CCRF-CEM | |
| Additional information | NA | |
| PubChem ID | 14335956 | |
| Additional PMIDs | NA | |
| Additional sources of information | https://powo.science.kew.org/taxon/urn:lsid:ipni.org:names:729396-1 | |
| Safety | NA |